Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Development of minimally invasive techniques for management of medically-complicated obesity.

Rashti F, Gupta E, Ebrahimi S, Shope TR, Koch TR, Gostout CJ.

World J Gastroenterol. 2014 Oct 7;20(37):13424-45. doi: 10.3748/wjg.v20.i37.13424. Review.

2.

Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients.

Vargas V, Allende H, Lecube A, Salcedo MT, Baena-Fustegueras JA, Fort JM, Rivero J, Ferrer R, Catalán R, Pardina E, Ramón Y Cajal S, Guardia J, Peinado-Onsurbe J.

World J Hepatol. 2012 Dec 27;4(12):382-8. doi: 10.4254/wjh.v4.i12.382.

3.

The role of the gut hormone GLP-1 in the metabolic improvements caused by ileal transposition.

Gaitonde S, Kohli R, Seeley R.

J Surg Res. 2012 Nov;178(1):33-9. doi: 10.1016/j.jss.2011.04.044. Epub 2011 May 18.

4.

Selective reduction in neural responses to high calorie foods following gastric bypass surgery.

Ochner CN, Kwok Y, Conceição E, Pantazatos SP, Puma LM, Carnell S, Teixeira J, Hirsch J, Geliebter A.

Ann Surg. 2011 Mar;253(3):502-7. doi: 10.1097/SLA.0b013e318203a289.

5.

Gastrojejunal stoma diameter predicts weight regain after Roux-en-Y gastric bypass.

Abu Dayyeh BK, Lautz DB, Thompson CC.

Clin Gastroenterol Hepatol. 2011 Mar;9(3):228-33. doi: 10.1016/j.cgh.2010.11.004. Epub 2010 Nov 17.

6.

Imaging in bariatric surgery: service set-up, post-operative anatomy and complications.

Shah S, Shah V, Ahmed AR, Blunt DM.

Br J Radiol. 2011 Feb;84(998):101-11. doi: 10.1259/bjr/18405029. Epub 2010 Nov 2. Review.

7.

Changes in neurohormonal gut peptides following bariatric surgery.

Ochner CN, Gibson C, Shanik M, Goel V, Geliebter A.

Int J Obes (Lond). 2011 Feb;35(2):153-66. doi: 10.1038/ijo.2010.132. Epub 2010 Jul 13. Review.

8.

Development of a sleeve gastrectomy weight loss model in obese Zucker rats.

Lopez PP, Nicholson SE, Burkhardt GE, Johnson RA, Johnson FK.

J Surg Res. 2009 Dec;157(2):243-50. doi: 10.1016/j.jss.2008.10.025. Epub 2008 Nov 24.

9.

Nephrolithiasis after bariatric surgery for obesity.

Lieske JC, Kumar R, Collazo-Clavell ML.

Semin Nephrol. 2008 Mar;28(2):163-73. doi: 10.1016/j.semnephrol.2008.01.009.

10.

Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions.

Salem L, Devlin A, Sullivan SD, Flum DR.

Surg Obes Relat Dis. 2008 Jan-Feb;4(1):26-32. Epub 2007 Dec 19.

11.
12.

Update on obesity surgery.

Eisenberg D, Duffy AJ, Bell RL.

World J Gastroenterol. 2006 May 28;12(20):3196-203. Review.

13.

Effects of bariatric surgery in older patients.

Sugerman HJ, DeMaria EJ, Kellum JM, Sugerman EL, Meador JG, Wolfe LG.

Ann Surg. 2004 Aug;240(2):243-7.

14.

Gastrointestinal complications of obesity surgery.

Pandolfino JE, Krishnamoorthy B, Lee TJ.

MedGenMed. 2004 Apr 20;6(2):15. Review. No abstract available.

15.

Laparoscopic versus open gastric bypass in the treatment of morbid obesity: a randomized prospective study.

Luján JA, Frutos MD, Hernández Q, Liron R, Cuenca JR, Valero G, Parrilla P.

Ann Surg. 2004 Apr;239(4):433-7.

16.

Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss.

Sugerman HJ, Wolfe LG, Sica DA, Clore JN.

Ann Surg. 2003 Jun;237(6):751-6; discussion 757-8.

17.

Gastric banding.

Kellum JM.

Ann Surg. 2003 Jan;237(1):17-8. No abstract available.

18.

Effective management of obesity.

O'Meara S, Glenny AM, Wilson C, Melville A, Sheldon TA.

Qual Health Care. 1997 Sep;6(3):170-5. Review. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk